explain me Liver function test frkom basic to clinical

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Finding Sources

Reading File

I now have all the material needed for a comprehensive answer. Let me compose the full explanation.

Liver Function Tests (LFTs): From Basic to Clinical

LFTs are a panel of blood tests used to detect liver injury, assess severity, monitor disease progression, and guide further workup. Despite the name, many of them reflect hepatocellular injury or cholestasis rather than true "function." True synthetic function is assessed by albumin, prothrombin time (PT/INR), and coagulation factors.

1. Basic Liver Physiology (Why These Tests Matter)

The liver performs hundreds of functions:

Metabolism of carbohydrates, lipids, proteins
Synthesis of albumin, clotting factors (I, II, V, VII, IX, X, XI), cholesterol
Detoxification of drugs, alcohol, ammonia
Bilirubin conjugation and excretion into bile
Bile production for fat absorption

When the liver is damaged, its cellular constituents (enzymes) leak into blood, its synthetic capacity drops, and bile flow is disrupted. LFTs capture all three.

2. Bilirubin Metabolism (The Foundation)

Understanding bilirubin is key to understanding LFTs.

Step 1 - Production (Pre-hepatic):

Heme from senescent RBCs is broken down → biliverdin → unconjugated (indirect) bilirubin
Unconjugated bilirubin is lipid-soluble, bound to albumin in blood - it cannot be filtered by kidneys, so it does NOT appear in urine

Step 2 - Hepatic processing (3 steps):

Uptake: The bilirubin-albumin complex reaches the hepatocyte; bilirubin dissociates and enters the cell
Conjugation: Bilirubin + glucuronic acid (via UDP-glucuronosyltransferase) → conjugated (direct) bilirubin - now water-soluble
Excretion: Hepatocyte pumps conjugated bilirubin into bile canaliculi - this is the rate-limiting step

Step 3 - Post-hepatic (intestinal):

Conjugated bilirubin → duodenum → colon bacteria convert it to urobilinogen
Urobilinogen: partly excreted in stool as stercobilin (makes stool brown), partly reabsorbed and excreted in urine (small amounts normal)

Clinical Rule:

Conjugated (direct) hyperbilirubinemia → water-soluble → appears in urine → "dark urine" (bilirubinuria); pale/clay-colored stool (bile not reaching gut)
Unconjugated (indirect) hyperbilirubinemia → albumin-bound → NOT in urine; normal stool color
Jaundice becomes visible at the frenulum/sclera at serum bilirubin ≥ 2.5 mg/dL, and in skin at ≥ 5 mg/dL

Normal total bilirubin: < 1.2 mg/dL (normally >90% is unconjugated)

3. The Individual Tests

3a. Bilirubin (Total, Direct, Indirect)

Fraction	Source	Key Conditions
Total bilirubin	Sum of both	Liver disease, hemolysis, obstruction
Direct (conjugated)	Processed by liver	Cholestasis, obstruction, hepatocellular disease
Indirect (unconjugated)	Not yet processed	Hemolysis, Gilbert syndrome, Crigler-Najjar, neonatal jaundice

Pre-hepatic (e.g., hemolysis): indirect ↑, direct normal
Hepatocellular (e.g., hepatitis): both fractions elevated (liver can't take up, conjugate, or excrete)
Post-hepatic/obstructive (e.g., choledocholithiasis): direct ↑ prominently

3b. Aminotransferases (AST and ALT) - Markers of Hepatocellular Injury

These enzymes are released when hepatocytes are damaged or die.

AST (Aspartate Aminotransferase)

Found in: liver, heart, skeletal muscle, kidney, RBCs
Less specific for liver - elevated also in MI, rhabdomyolysis
Normal: 10-40 U/L

ALT (Alanine Aminotransferase)

Found predominantly in: liver cytoplasm
More specific for liver disease
Normal: 7-56 U/L

Clinical Interpretation:

Magnitude of elevation	Likely cause
>10x upper reference limit (URL)	Acute hepatitis (viral, ischemic, drug-induced)
3-10x URL	Chronic hepatitis, alcoholic hepatitis
<3x URL with AST > ALT	Cirrhosis, alcoholic liver disease

The AST:ALT Ratio:

AST:ALT > 2:1 strongly suggests alcoholic liver disease (alcohol depletes pyridoxal phosphate needed for ALT synthesis; AST is also released from mitochondria in alcohol-damaged cells)
AST:ALT < 1 is typical of viral hepatitis and NAFLD
In cirrhosis, the ratio tends toward >1 even without alcohol

Important Pearl: In acute viral hepatitis, ALT rises significantly days before jaundice appears.

3c. Alkaline Phosphatase (ALP) - Marker of Cholestasis

Location: Expressed on bile duct epithelium (canalicular membrane), also bone osteoblasts, placenta, intestine
Mechanism of elevation: In biliary obstruction/cholestasis, ALP synthesis increases and enzyme is released into serum
Half-life: ~7 days - levels may lag behind resolution of obstruction
Normal: 44-147 U/L (varies by age/sex)

Causes of elevated ALP:

Hepatobiliary: bile duct obstruction (choledocholithiasis, cholangiocarcinoma, PSC), intrahepatic cholestasis, PBC, drug-induced cholestasis, liver metastases, space-occupying lesions
Non-hepatic: bone disease (Paget's, bone metastases, fractures, hyperparathyroidism), pregnancy (placental isoform), growing children

How to confirm ALP is of liver origin: Check GGT (see below) or ALP isoenzyme fractionation. If GGT is elevated alongside ALP, the source is hepatobiliary.

3d. Gamma-Glutamyl Transferase (GGT) - Cholestasis Confirmatory Marker

Location: Liver (especially bile duct epithelium), kidney, pancreas
Sensitive for hepatobiliary disease but not specific
Key uses:
- Confirm hepatobiliary origin of elevated ALP
- GGT elevated in cholestasis with ALP = strongly cholestatic pattern
- GGT elevated without ALP elevation → suspect alcohol use or drug induction (GGT is a classic marker of chronic alcohol use)
- In suspected choledocholithiasis: sensitivity ~90%, specificity ~85%
Important: GGT levels increase earlier and persist longer than traditional LFTs in cholestatic disease
Also a prognostic marker - rising GGT over time is associated with type 2 diabetes, metabolic syndrome, and cardiovascular mortality

3e. Albumin - Marker of Chronic Synthetic Function

Synthesized exclusively in the liver (~10 g/day)
Half-life: 15-20 days - therefore a poor marker of acute liver dysfunction; reflects chronic impairment
Normal: 3.5-5.0 g/dL
Decreased in: cirrhosis, chronic hepatitis, malnutrition, nephrotic syndrome, protein-losing enteropathy, inflammatory states (albumin is a negative acute-phase reactant)

Clinical significance:

Low albumin + prolonged PT = advanced/chronic liver disease with impaired synthetic capacity
In the LFT diagnostic algorithm: decreased albumin in hepatocellular pattern = chronic hepatitis; normal albumin = acute hepatitis

3f. Prothrombin Time (PT) / INR - Marker of Acute Synthetic Function

The liver synthesizes all clotting factors EXCEPT factor VIII
Factor VII has the shortest half-life (~6 hours) - making PT/INR the most sensitive marker of acute hepatic synthetic failure
PT/INR becomes abnormal only with significant hepatic impairment (the liver has large synthetic reserve)
Normal PT: 11-13.5 seconds; Normal INR: 0.8-1.1

Critical distinction:

Vitamin K deficiency also prolongs PT (factors II, VII, IX, X require vitamin K for γ-carboxylation) - can distinguish by giving IV vitamin K: a ≥30% improvement in PT = vitamin K deficiency, not liver failure
In DIC, factor VIII is also low (unlike in liver disease where factor VIII is normal or increased, since it is made by endothelial cells)

Clinical uses:

Prognostic scoring: INR is a component of MELD score (Model for End-Stage Liver Disease) along with creatinine and bilirubin - used to prioritize liver transplant allocation
Prognosis in acute liver failure (acetaminophen toxicity, acute viral hepatitis)
Prognosis in alcoholic hepatitis (part of Maddrey Discriminant Function)

3g. Total Protein and Globulins

Total protein = albumin + globulins
Increased globulins with decreased albumin = chronic liver disease (liver makes less albumin; plasma cells produce more immunoglobulins in chronic inflammation/cirrhosis)
Albumin:Globulin (A:G) ratio reversal (<1) suggests chronic liver disease

3h. Lactate Dehydrogenase (LDH)

Non-specific; present in liver, heart, muscle, RBCs
Markedly elevated LDH with modest transaminase rise may suggest ischemic hepatitis ("shock liver") or hepatic malignancy

4. Pattern Recognition - The Clinical Core

This is how LFTs are used at the bedside. Two main patterns exist:

Hepatocellular Pattern

ALT and AST >> ALP
Liver parenchyma (hepatocytes) are injured
Causes: viral hepatitis (A, B, C, E), alcoholic hepatitis, NAFLD/NASH, autoimmune hepatitis, drug-induced liver injury (e.g., acetaminophen), ischemic hepatitis, Wilson disease

Cholestatic Pattern

ALP (+ GGT) >> ALT/AST
Bile flow is obstructed (intra- or extrahepatic)
Causes: choledocholithiasis, cholangiocarcinoma, PSC, PBC, drug-induced cholestasis (e.g., estrogens, chlorpromazine), pancreatic head tumor

Diagnostic Algorithms

From the Tietz Textbook of Laboratory Medicine:

Algorithm for using abnormal LFTs to classify liver disease

Figure: When AST > 3x URL with ALP < 2x URL = Hepatocellular disease. When ALP > 2x URL with AST < 3x URL = Cholestatic disease. Albumin then stratifies acute vs chronic.

Algorithm differentiating causes of abnormal liver-associated enzymes

Figure: Hepatocellular pattern: >10x URL = acute hepatitis; <10x URL = chronic hepatitis. If AST > ALT = check for cirrhosis. Cholestatic pattern: dilated ducts = extrahepatic obstruction; normal ducts = intrahepatic cholestasis.

5. Summary Table of All LFTs

Test	Normal Range	What it Reflects	Elevated In	Clinical Pearl
Total Bilirubin	<1.2 mg/dL	Liver excretion, hemolysis	Jaundice of any cause	>2.5 mg/dL = clinical icterus
Direct (Conjugated) Bilirubin	<0.3 mg/dL	Conjugation/excretion	Obstruction, hepatocellular	Appears in urine (dark urine)
Indirect Bilirubin	<1.0 mg/dL	Hemolysis, conjugation defects	Hemolysis, Gilbert, neonatal	NOT in urine
ALT	7-56 U/L	Hepatocyte integrity (specific)	Hepatitis, NAFLD, drugs	Best marker of hepatocellular injury
AST	10-40 U/L	Hepatocyte integrity (non-specific)	Hepatitis, alcohol, cardiac, muscle	AST:ALT >2 = alcoholic liver disease
ALP	44-147 U/L	Bile duct epithelium, bone	Cholestasis, bone disease	Confirm with GGT to prove liver origin
GGT	9-48 U/L	Bile canaliculi, microsomal induction	Cholestasis, alcohol, drugs	Confirms ALP is hepatic; rises early in cholestasis
Albumin	3.5-5.0 g/dL	Chronic synthetic function	↓ in cirrhosis, malnutrition	Half-life 15-20 days; not acute marker
PT/INR	PT 11-13.5s / INR <1.1	Acute synthetic function	Acute/severe liver disease	Factor VII t½ = 6 hrs; used in MELD score

6. Key Clinical Scenarios

Acute Viral Hepatitis: ALT > AST (both markedly elevated, often >10x URL), bilirubin elevated, ALP mildly elevated, albumin normal (acute, so synthetic function preserved unless fulminant), PT may be elevated in severe cases.

Alcoholic Hepatitis: AST:ALT ratio > 2:1 (but rarely >8x URL), GGT markedly elevated, bilirubin elevated, PT prolonged (Maddrey score uses PT to assess severity).

Obstructive Jaundice (e.g., gallstone in common bile duct): ALP and GGT markedly elevated, conjugated bilirubin predominates, dark urine + pale stools, AST/ALT mildly elevated (can be significantly elevated acutely).

Cirrhosis: ALT/AST mildly elevated (burnt-out liver), AST > ALT, low albumin, prolonged PT, elevated bilirubin in decompensation, low platelet count (from hypersplenism).

Non-Alcoholic Fatty Liver Disease (NAFLD/NASH): ALT > AST mildly elevated (usually 1-3x URL), ALP mildly elevated or normal.

Primary Biliary Cholangitis (PBC): ALP and GGT markedly elevated, anti-mitochondrial antibodies (AMA) positive.

Ischemic Hepatitis ("Shock Liver"): Massive AST and ALT rise (often >50x URL), LDH very high, improves rapidly with restoration of perfusion.

7. LFTs and the MELD Score

The MELD (Model for End-Stage Liver Disease) score uses:

INR
Total bilirubin
Serum creatinine

It predicts 90-day mortality in cirrhosis and is used worldwide for liver transplant prioritization.

MELD = 3.78 × ln[bilirubin mg/dL] + 11.2 × ln[INR] + 9.57 × ln[creatinine mg/dL] + 6.43

8. A Practical Note on "LFTs are not really function tests"

As Sabiston's Textbook of Surgery notes, "standard liver function tests (LFTs) are generally NOT tests of function" - a critical distinction. Most tests (AST, ALT, ALP, GGT) measure hepatocyte injury or enzyme leakage, not liver capacity. Only albumin and PT/INR truly reflect the liver's functional reserve.

Sources:

Harper's Illustrated Biochemistry, 32nd Ed
Tietz Textbook of Laboratory Medicine, 7th Ed
Schwartz's Principles of Surgery, 11th Ed
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Symptom to Diagnosis: An Evidence-Based Guide, 4th Ed
Sabiston Textbook of Surgery, p. 31-42

This is a shared conversation. Sign in to Orris to start your own chat.